Filana Therapeutics, Inc. Common Stock

FLNANASDAQ • USD
0.48 USD
↗ 0.01 (1.92%)🟢LIVE (AS OF 02:20 PM EST)
🟢Market: OPEN

Shares of Filana Therapeutics, Inc. Common Stock (FLNA) are trading at $0.48. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. Key drivers include negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, FLNA appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 16, 2026.

Open?$0.47
High?$0.49
Low?$0.47
Prev. Close?$0.47
Volume?420.1K
Avg. Volume?433.4K
VWAP?$0.48
Rel. Volume?0.97x
Bid / Ask
Bid?$0.41 × 100
Ask?$0.55 × 200
Spread?$0.15
Midpoint?$0.48
Valuation & Ratios
Market Cap?23.6M
Shares Out?50.3M
Float?45.8M
Float %?94.9%
P/E Ratio?N/A
P/B Ratio?0.41
EPS?-$0.84
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
Employees
20
Market Cap
23.6M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2000-07-14
Address
6801 N CAPITAL OF TEXAS HIGHWAY
AUSTIN, TX 78731
Phone: 512-501-2444
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestVery High
Short % of Float?12.40%High
Short Interest?5.7M
Days to Cover?20.6
Free Float45.8M
Avg Daily Volume275.8K
Settlement Date2026-10-30
Financial Health
Current Ratio?1.91Adequate
Quick Ratio?1.91Adequate
Cash Ratio?1.12Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.41CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.5CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-72.8%WEAK▾
ROA?
S&P
3
-42.2%WEAK▾
Cash Flow & Enterprise
FCF?$-29128000
Enterprise Value?$-23349000
Fundamentals ratios updated end of day